Takakazu Morita

This inventor holds 12 USPTO granted patents. Top assignees: Santen Pharmaceutical Co., Ltd., Eisai Company, Limited. Active years: 1991-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takakazu Morita. Retrieved from https://idiyas.com/inventor/takakazu-morita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 29(Granted Patents)

Company Filing History:

12 out of 282

Santen Pharmaceutical Co., Ltd.

patents

1 out of 677

Eisai Company, Limited

patents

where one patent can have more than one assignee

Years Active: 1991-1994

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5292926 - Cysteine derivatives (1994-03-08),

2. 5290774 - Photostabilizing method for ophthalmic solutions and the resulting (1994-03-01),

3. 5256655 - Bicyclic sulfur-containing compounds (1993-10-26),

4. 5214181 - Amino acid derivatives (1993-05-25),

5. 5202342 - N-alkyl thiazolidine derivatives (1993-04-13),

6. 5183816 - Bicyclic sulfur-containing compounds (1993-02-02),

7. 5153198 - Agent for treatment of disorders of the cerebro-neural transmission (1992-10-06),

8. 5128467 - Cyclic sulfur-containing compounds (1992-07-07),

9. 5087627 - Agent for treatment of disorders of the cerebro-neural transmission (1992-02-11),

10. 5082836 - Compositions and methods of use of cyclic sulfur-containing compounds (1992-01-21),

11. 5041435 - Cyclic sulfur-containing compounds (1991-08-20),

12. 5034230 - Anti-allergic ophthalmics (1991-07-23),

Title: The Innovations of Takakazu Morita

Introduction

Takakazu Morita is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on developing innovative solutions that address various medical challenges.

Latest Patents

Among his latest patents, Morita has developed cysteine derivatives, which are useful as immunomodulators and for the treatment of liver disorders. This invention relates to cysteine derivatives of a specific formula and their salts. Additionally, he has created a photostabilizing method for ophthalmic solutions. This method enhances the stability of ophthalmic solutions by incorporating polyhydric alcohol and boric acid, or sodium borate, to protect drug substances that are sensitive to light.

Career Highlights

Throughout his career, Morita has worked with notable companies in the pharmaceutical industry, including Santen Pharmaceutical Co., Ltd. and Eisai Company, Limited. His expertise and innovative approach have made a significant impact on the development of new medical treatments.

Collaborations

Morita has collaborated with esteemed colleagues such as Shiro Mita and Tadashi Iso. Their combined efforts have contributed to the advancement of pharmaceutical innovations.

Conclusion

Takakazu Morita's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of effective medical solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]